Investors & Media
Overview
GENFIT is a biopharmaceutical company committed to improving the lives of patients with rare, life-threatening liver diseases whose medical needs remain largely unmet. GENFIT is a pioneer in liver disease research and development with a rich history and a solid scientific heritage spanning more than two decades
Stock Information
Upcoming Events
April 2, 2026
May 21, 2026
June 15, 2026